Combined chemotherapy and radiotherapy in diffuse large cell immunoblastic lymphoma: A phase II study of CHOP/bleomycin/methotrexate alternating with ifosfamide/methotrexate/etoposide
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in Clinical Oncology
- Vol. 7 (2) , 113-116
- https://doi.org/10.1016/s0936-6555(05)80813-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Nonlymphoblastic lymphoma in children--histology and stage-related response to therapy: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1991
- Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non‐hodgkin's lymphoma after failure of the LNH 84 regimenHematological Oncology, 1991
- Toxicity and preliminary results with a new eight‐drug regimen (CEOP‐IMVP‐DEXA) in the treatment of aggressive lymphomasHematological Oncology, 1991
- Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphomaHematological Oncology, 1991
- Non-Hodgkin's lymphomas of childhood: an analysis of the histology, staging, and response to treatment of 338 cases at a single institution.Journal of Clinical Oncology, 1989
- Poor-risk non-lymphoblastic lymphoma of childhood: Results of an intensive pilot studyMedical and Pediatric Oncology, 1989
- Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study.Journal of Clinical Oncology, 1986
- Chemotherapy for Large-Cell Lymphoma: Optimism and CautionAnnals of Internal Medicine, 1985
- Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic typeThe American Journal of Medicine, 1983